Cytotoxic T lymphocytes and natural killer cells display impaired cytotoxic functions and reduced activation in patients with alcoholic hepatitis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 308, Issue 4, 2015, Pages G269-G276

  Støy, Sidsel ^a   Dige, Anders ^a   Sandahl, Thomas Damgaard ^a   Laursen, Tea Lund ^a   Buus, Christian ^b   Hokland, Marianne ^b   Vilstrup, Hendrik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Alcoholic hepatitis; Cytotoxic T lymphocytes; Degranulation; Natural killer cells; Natural killer group 2 D

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 22; NATURAL KILLER CELL RECEPTOR NKG2D; CD56 ANTIGEN; IFNG PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; KLRK1 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; NCAM1 PROTEIN, HUMAN;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ARTICLE; BLOOD SAMPLING; CELL ACTIVATION; CELL MEDIATED CYTOTOXICITY; CHILD PUGH SCORE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DISEASE SEVERITY; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; INFECTION RISK; LIVER CELL; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOPENIA; MALE; NATURAL KILLER CELL; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; BLOOD; CASE CONTROL STUDY; CELLULAR IMMUNITY; COCULTURE; DEGRANULATION; HEPATITIS, ALCOHOLIC; IMMUNOLOGY; K562 CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TIME;

ADULT; ANTIGENS, CD56; CASE-CONTROL STUDIES; CELL DEGRANULATION; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HEPATITIS, ALCOHOLIC; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; INTERLEUKINS; K562 CELLS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOPENIA; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS;

EID: 84922875071     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00200.2014     Document Type: Article

References (51)

1. Aarhus University Hospital. DoCBLrv. http://www.auh.dk/om+auh/afdelinger/klinisk+biokemisk+afdeling/for+sundhedsfaglige/analysefortegnelse/hospital. (Lymphocyte reference values) 08.03.2014.
2. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294: 15-22, 2004.
3. Bouzani M, Ok M, McCormick A, Ebel F, Kurzai O, Morton CO, Einsele H, Loeffler J. Human NK cells display important antifungal activity against Aspergillus fumigatus, which is directly mediated by IFN-gamma release. J Immunol 187: 1369-1376, 2011.
4. Bryceson YT, Fauriat C, Nunes JM, Wood SM, Bjorkstrom NK, Long EO, Ljunggren HG. Functional analysis of human NK cells by flow cytometry. Methods Mol Biol 612: 335-352, 2010.
5. Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JK, Doherty JM, Mills JC, Colonna M. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457: 722-725, 2009.
6. Chiang SC, Theorell J, Entesarian M, Meeths M, Mastafa M, Al-Herz W, Frisk P, Gilmour KC, Ifversen M, Langenskiold C, Machaczka M, Naqvi A, Payne J, Perez-Martinez A, Sabel M, Unal E, Unal S, Winiarski J, Nordenskjold M, Ljunggren HG, Henter JI, Bryceson YT. Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocy-tosis but differences in cytokine production. Blood 121: 1345-1356, 2013.
7. Child CG, Turcotte JG. Surgery and portal hypertension. In: The Liver and Portal Hypertension, edited by Child CG. Philadelphia, PA: Saunders, 1964, p. 50-64.
8. Deleuran T, Gronbaek H, Vilstrup H, Jepsen P. Cirrhosis and mortality risks of biopsy-verified alcoholic pure steatosis and steatohepatitis: a nationwide registry-based study. Alimen Pharmacol Ther 35: 1336-1342, 2012.
9. Domaica CI, Fuertes MB, Uriarte I, Girart MV, Sardanons J, Comas DI, Di Giovanni D, Gaillard MI, Bezrodnik L, Zwirner NW. Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development. PLoS One 7: e51677, 2012.
10. Godshall CJ, Scott MJ, Burch PT, Peyton JC, Cheadle WG. Natural killer cells participate in bacterial clearance during septic peritonitis through interactions with macrophages. Shock 19: 144-149, 2003.
11. Groscurth P. Cytotoxic effector cells of the immune system. Anat Embryol 180: 109-119, 1989.
12. Hou X, Zhou R, Wei H, Sun R, Tian Z. NKG2D-retinoic acid early inducible-1 recognition between natural killer cells and Kupffer cells in a novel murine natural killer cell-dependent fulminant hepatitis. Hepatology 49: 940-949, 2009.
13. Jamieson AM, Diefenbach A, McMahon CW, Xiong N, Carlyle JR, Raulet DH. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17: 19-29, 2002.
14. Jaruga B, Hong F, Kim WH, Sun R, Fan S, Gao B. Chronic alcohol consumption accelerates liver injury in T cell-mediated hepatitis: alcohol disregulation of NF-kappaB and STAT3 signaling pathways. Am J Physiol Gastrointest Liver Physiol 287: G471-G479, 2004.
15. Jeong WI, Park O, Gao B. Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis. Gastroenterology 134: 248-258, 2008.
16. Jepsen P, Vilstrup H, Mellemkjaer L, Thulstrup AM, Olsen JH, Baron JA, Sorensen HT. Prognosis of patients with a diagnosis of fatty liver-a registry-based cohort study. Hepato-gastroenterology 50: 2101-2104, 2003.
17. Kahraman A, Schlattjan M, Kocabayoglu P, Yildiz-Meziletoglu S, Schlensak M, Fingas CD, Wedemeyer I, Marquitan G, Gieseler RK, Baba HA, Gerken G, Canbay A. Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis. Hepatology 51: 92-102, 2010.
18. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D’Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology 33: 464-470, 2001.
19. Ki SH, Park O, Zheng M, Morales-Ibanez O, Kolls JK, Bataller R, Gao B. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 52: 1291-1300, 2010.
20. Kim CH, Johnston B, Butcher EC. Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity. Blood 100: 11-16, 2002.
21. King PT, Ngui J, Farmer MW, Hutchinson P, Holmes PW, Hold-sworth SR. Cytotoxic T lymphocyte and natural killer cell responses to non-typeable Haemophilus influenzae. Clin Exp Immunol 152: 542-551, 2008.
22. Kohga K, Takehara T, Tatsumi T, Ohkawa K, Miyagi T, Hiramatsu N, Kanto T, Kasugai T, Katayama K, Kato M, Hayashi N. Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma. Cancer Sci 99: 1643-1649, 2008.
23. Kong X, Feng D, Wang H, Hong F, Bertola A, Wang FS, Gao B. Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis (Abstract). Hepatology 2: 25744, 2012.
24. Kramer B, Korner C, Kebschull M, Glassner A, Eisenhardt M, Nischalke HD, Alexander M, Sauerbruch T, Spengler U, Natter-mann J. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis. Hepatology 56: 1201-1213, 2012.
25. Laso FJ, Madruga JI, Giron JA, Lopez A, Ciudad J, San Miguel JF, Alvarez-Mon M, Orfao A. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption. Hepatology 25: 1096-1100, 1997.
26. Laso FJ, Madruga JI, Lopez A, Ciudad J, Alvarez-Mon M, San Miguel J, Orfao A. Abnormalities of peripheral blood T lymphocytes and natural killer cells in alcoholic hepatitis persist after a 3-month withdrawal period. Alcohol Clin Exp Res 21: 672-676, 1997.
27. Li J, Han Y, Jin K, Wan Y, Wang S, Liu B, Liu Y, Lu S, Huang Z. Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infection (Abstract). Virol J 8: 199, 2011.
28. Li N, Puga Yung GL, Pradier A, Toso C, Giostra E, Morard I, Spahr L, Seebach JD. NK cell isolation from liver biopsies: phenotypic and functional analysis of low cell numbers by flow cytometry (Abstract). Front Immunol 4: 61, 2013.
29. Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75: 193-199, 1978.
30. Marquez M, Fernandez-Gutierrez C, Montes-de-Oca M, Blanco MJ, Brun F, Rodriguez-Ramos C, Giron-Gonzalez JA. Chronic antigenic stimuli as a possible explanation for the immunodepression caused by liver cirrhosis. Clin Exp Immunol 158: 219-229, 2009.
31. Melhem A, Muhanna N, Bishara A, Alvarez CE, Ilan Y, Bishara T, Horani A, Nassar M, Friedman SL, Safadi R. Antifibrotic activity of NK cells in experimental liver injury through killing of activated HSC. J Hepatol 45: 60-71, 2006.
32. Merayo-Chalico J, Gomez-Martin D, Pineirua-Menendez A, Santana De Anda K, Alcocer-Varela J. Lymphopenia as risk factor for development of severe infections in patients with systemic lupus erythematosus: a case-control study. Q J Med 106: 451–457, 2013.
33. Minagawa M, Deng Q, Liu ZX, Tsukamoto H, Dennert G. Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption. Gastroenterology 126: 1387–1399, 2004.
34. Montoya CJ, Pollard D, Martinson J, Kumari K, Wasserfall C, Mulder CB, Rugeles MT, Atkinson MA, Landay AL, Wilson SB. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11. Immunology 122: 1-14, 2007.
35. Nath B, Szabo G. Alcohol-induced modulation of signaling pathways in liver parenchymal and nonparenchymal cells: implications for immunity. Semin Liver Dis 29: 166-177, 2009.
36. Oliviero B, Varchetta S, Paudice E, Michelone G, Zaramella M, Mavilio D, De Filippi F, Bruno S, Mondelli MU. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 137: 1151-1160, 2009.
37. Orntoft NW, Sandahl TD, Jepsen P, Vilstrup H. Short-term and long-term causes of death in patients with alcoholic hepatitis in Denmark. Clin Gastroenterol Hepatol 12: 1739-1744, 2014.
38. Park O, Wang H, Weng H, Feigenbaum L, Li H, Yin S, Ki SH, Yoo SH, Dooley S, Wang FS, Young HA, Gao B. In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression. Hepatology 54: 252-261, 2011.
39. Poli A, Michel T, Theresine M, Andres E, Hentges F, Zimmer J. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 126: 458–465, 2009.
40. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60: 646-649, 1973.
41. Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology 130: 435–452, 2006.
42. Radaeva S, Sun R, Pan HN, Hong F, Gao B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39: 1332-1342, 2004.
43. Roselle GA, Mendenhall CL, Grossman CJ, Weesner RE. Lymphocyte subset alterations in patients with alcoholic hepatitis. J Clin Lab Immunol 26: 169-173, 1988.
44. Sandahl TD, Jepsen P, Thomsen KL, Vilstrup H. Incidence and mortality of alcoholic hepatitis in Denmark 1999-2008: a nationwide population based cohort study. J Hepatol 54: 760-764, 2011.
45. Stadlbauer V, Mookerjee RP, Wright GA, Davies NA, Jurgens G, Hallstrom S, Jalan R. Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol 296: G15-G22, 2009.
46. Stoy S, Sandahl TD, Dige AK, Agnholt J, Rasmussen TK, Gronbaek H, Deleuran B, Vilstrup H. Highest frequencies of interleukin-22-producing T helper cells in alcoholic hepatitis patients with a favourable short-term course. PloS one 8: e55101, 2013.
47. Tajiri K, Shimizu Y, Tsuneyama K, Sugiyama T. Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 21: 673-680, 2009.
48. Thomsen KL, Hebbard L, Glavind E, Clouston A, Vilstrup H, George J, Gronbaek H. Non-alcoholic steatohepatitis weakens the acute phase response to endotoxin in rats. Liver Int 34: 1584–1592, 2014.
49. Vilarinho S, Ogasawara K, Nishimura S, Lanier LL, Baron JL. Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus. Proc Natl Acad Sci USA 104: 18187–18192, 2007.
50. Wiemann K, Mittrucker HW, Feger U, Welte SA, Yokoyama WM, Spies T, Rammensee HG, Steinle A. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo. J Immunol 175: 720–729, 2005.
51. Xu CF, Yu CH, Li YM, Xu L, Du J, Shen Z. Association of the frequency of peripheral natural killer T cells with nonalcoholic fatty liver disease. World J Gastroenterol 13: 4504–4508, 2007.